文献速递慢性静脉疾病

穿通静脉再次射频消融的成功率及预测因素

Success rate and factors predictive of redo radiofrequency ablation of perforator veins.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2018-04-18

该回顾性分析纳入2009至2015年256例穿通静脉功能不全患者的642次射频消融手术,其中52条穿通静脉行再次消融。再次消融早期闭合率67.3%,平均随访24个月闭合率65.38%,与初次技术成功率64.9%相当。射频针温度85°C及穿通静脉位于小腿中远端与再通相关。

要点

  • 再次穿通静脉射频消融早期闭合率67.3%,平均随访24个月闭合率65.38%。
  • 初次射频消融技术成功率为64.9%。
  • 射频针温度85°C者再通概率高于90°C和95°C者(P = .01)。

核心结论

  • 穿通静脉初次与再次射频消融的成功闭合率相当,数据支持再次穿通静脉消融的效用,并提示射频针温度和穿通静脉位置可能预测成功结局或再通。

研究设计与样本

  • 回顾性分析2009至2015年256例因穿通静脉功能不全接受射频消融的642次手术,均为初始保守治疗无效者。
  • 术后3至7天行双功能超声检查,成功闭合定义为术后扫描无彩色血流。
  • 再通定义为随访时症状患者靶血管在双功能超声上出现反流。
  • 随访第一年每3个月一次,之后每6个月一次。

主要发现

  • 642次手术中52条穿通静脉行再次消融,涉及29例患者(14例女性)、37条肢体,平均年龄65岁(标准差±15岁)。
  • 再次消融患者CEAP分级:C1为0、C2为0、C3为3、C4a为11、C4b为7、C5为0、C6为16。
  • 靶穿通静脉分布:小腿40条、踝部12条;平均最大直径4.6 mm(标准差±1.1 mm)。
  • 初次技术成功率为64.9%,再次手术早期闭合率为67.3%,平均随访24个月(标准差±16.8个月)时闭合率为65.38%。
  • 再次手术成功闭合与年龄(P = .54)、性别(P = .14)、临床分级(P = .82)、侧别(P = .84)或静脉位置(P = .54)无临床相关性。

关键数值与推荐

  • 成功闭合定义:术后双功能超声扫描无彩色血流。
  • 再通定义:随访时症状患者靶血管在双功能超声上出现反流。

临床怎么用

  • 原文结论认为数据支持再次穿通静脉消融的效用,并提示射频针温度和穿通静脉位置可能预测成功结局或再通。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Radiofrequency ablation (RFA) is increasingly being employed for treatment of perforator vein insufficiency and venous ulcer healing. Previous studies have shown a closure rate of 60% to 80% in incompetent perforator veins (IPVs) with RFA. The purpose of the study was to determine the utility of a redo RFA for symptomatic recanalized perforators and to predict factors associated with recanalization. METHODS: A retrospective analysis of 642 procedures in 256 patients with venous insufficiency due to IPVs from 2009 to 2015 was conducted. All 642 procedures were performed using RFA in patients who failed to respond to initial conservative management. Postoperative duplex ultrasound scans were performed within 3 to 7 days. Successful obliteration was defined as lack of color flow on postoperative scan. Recanalization was defined as presence of reflux on duplex ultrasound in symptomatic patients in the targeted vessel at follow-up. Follow-ups were conducted every 3 months in the first year and every 6 months thereafter. RESULTS: Among the 642 procedures, redo ablation was performed in 52 IPVs (29 patients, 37 extremities) including 14 women, with mean age of 65 years (standard deviation [SD], ±15 years). The Clinical, Etiology, Anatomy, and Pathophysiology class of the patients was as follows: C1, 0; C2, 0; C3, 3; C4a, 11; C4b, 7; C5, 0; and C6, 16. The distribution of the targeted IPVs included the calf (40) and ankle (12). The mean maximum diameter of the targeted veins was 4.6 mm (SD, ±1.1 mm). The initial technical success rate was 64.9%. Redo procedures had an early closure rate of 67.3%. At follow-up after a mean duration of 24 months (SD, ±16.8 months), the closure rate was 65.38%. No clinical correlation was found between successful obliteration in the redo procedure and age (P = .54), sex (P = .14), clinical class (P = .82), laterality (P = .84), or location of the vein (P = .54). When data were compared to predict factors associated with a redo procedure, IPVs located in mid and distal calf areas tended to recanalize more compared with the ankle (P = .04). Temperature of the radiofrequency stylet also showed a linear association, with patients treated at 85°C having higher probability of recanalization compared with patients treated at 90°C and 95°C (P = .01). CONCLUSIONS: The rates of successful closure for IPVs on initial and redo procedures are comparable. The data validate the utility of performing redo perforator ablations and suggest that temperature of the radiofrequency stylet and location of the IPVs may be predictive of a successful outcome or recanalization.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Aurshina A, Ascher E, Mount L, et al. Success rate and factors predictive of redo radiofrequency ablation of perforator veins. J Vasc Surg Venous Lymphat Disord. 2018. PMID: 29678685. doi:10.1016/j.jvsv.2018.01.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。